Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

G5 Entertainment - Weaker sales and margins

07 augusti 2025

<a id="bm-comp-bd6d9eea-a50e-401c-9254-ce991d09e1bb" name="bm-comp-bd6d9eea-a50e-401c-9254-ce991d09e1bb" class="BMCustomAnchor"></a><table><tr><td bm-component-id="bd6d9eea-a50e-401c-9254-ce991d09e1bb" style="vertical-align: top; width:100.000000%;"><ul><li>Adj. EBIT -29% vs FactSet consensus; FX adj sales -11% y-o-y</li><li>Estimates to come down 8-10% on slower growth</li><li>Share has underperformed into numbers, trade at 5-4x EBIT '25e-'27e</li></ul></td></tr></table><a id="bm-comp-5c9fd1db-b9b6-485b-baf3-ebbaa5401a28" name="bm-comp-5c9fd1db-b9b6-485b-baf3-ebbaa5401a28" class="BMCustomAnchor"></a><table><tr><td bm-component-id="5c9fd1db-b9b6-485b-baf3-ebbaa5401a28" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">Q2 results</h3><p>Sales SEK 232m (-5% vs ABGSCe 245m and -8% vs cons 252m), where currency adjusted growth was -11% y-o-y (vs ABGSCe -5%) and -2% q-o-q. Adj. EBIT was 16m (-28% vs ABGSCe 22m and -29% vs cons 22m) for 6.8% margin (8.8%), and net profit 7m (-67% vs ABGSCe 21m and -67% vs cons 21m). LTM FCF has held up better than EBIT and was 136m (vs 95m adj. EBIT). Gross margin continued to improve to 70% (68%), driven by G5 Store, but is still not enough to offset the top-line trend. However, efforts ongoing to bring third-party games for distribution in G5 Store, which could contribute to accelerating top-line growth.</p><h3 class="bm-h3">Preliminary estimate changes</h3><p>We expect that FactSet consensus will cut its adj. EBIT estimates by 8-10% on '25e-'27e on the back of slower sales growth in Q2. That being said, we still believe organic growth could turn positive from Q4'25 if the global launch of Twilight Land or third-party games on G5 Store are successful.</p><h3 class="bm-h3">Final thoughts</h3><p>The report was weaker than expected, primarily driven by weaker sales. The growth trend remains negative, but improved somewhat q-o-q adjusted for FX. And with new game releases finally expected to arrive near-term, we could see further acceleration in H2. Moreover, management will hopefully talk more about buybacks on the call at 8.45 CET (<a data-bm-trackable="false" href="https://us06web.zoom.us/j/81702440968" target="_blank">link</a>), given its strong cash position and FCF. Lastly, the share has been weak into numbers (-14% L3M vs OMXSGI +4%) and trade at 5-4x EV/adj. EBIT on our un-updated '25e-'27e.</p><table id="bm-img-3f5e7324-2e91-4d2d-bfa6-235e2e0971ee" class="bm-img-table xslt-img-empty xslt-img-include"><tr><td class="xslt-img-caption">Deviation table</td></tr><tr><td><img bm-img-encrypt="3f5e7324-2e91-4d2d-bfa6-235e2e0971ee" bm-img-original-height="679" bm-img-original-width="855" bm-img-svg="image:image_upload/89501_cb46ce7f-4d2f-4956-801c-003d2d325ec3.svg" bm-img-width-hint="100%" id="bm-id-3f5e7324-2e91-4d2d-bfa6-235e2e0971ee" src="https://abgsc.bluematrix.com/images/image_upload/89501_cb46ce7f-4d2f-4956-801c-003d2d325ec3_733.png" svg="/nas/web/clients/abgsc/images/image_upload/89501_cb46ce7f-4d2f-4956-801c-003d2d325ec3.svg" width="727" alt="" title="" /></td></tr><tr><td class="xslt-img-source">Source: ABG Sundal Collier, company data, FactSet</td></tr></table></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-07-10 StrongPoint - Solid Q2 performance StrongPoint Analys
2026-07-10 Careium - Growth's comeback tour continues Careium Analys
2026-07-09 Infrea - Road tripping with Netel Infrea Analys
2026-07-08 Alligo - Softer growth, but margin recovery conti... Alligo Analys
2026-07-08 Qliro - Key earnings drivers intact Qliro Analys
2026-07-07 Nexam Chemical - We expect a firmer sequential qu... Nexam Chemical Analys
2026-07-07 Eastnine - Adding in Warsaw Eastnine Analys
2026-07-06 Ovzon - No Q2 fireworks, but plenty of fuel Ovzon Analys
2026-07-05 StrongPoint - Steady through the transition StrongPoint Analys
2026-07-03 Ascelia Pharma - Complete Response Letter for Orv... Ascelia Pharma Analys
2026-07-03 Fastpartner - Positive development on IFPM guidan... Fastpartner Analys
2026-07-02 Fastpartner - Q2 on the soft side but positive gu... Fastpartner Analys
2026-07-01 Prevas - Waiting for volumes to follow Prevas Analys
2026-07-01 Midsona - Top-line recovery around the corner Midsona Analys
2026-07-01 Nolato - Nearing organic growth acceleration Nolato Analys
2026-07-01 Eltel - New services improving the financial profile Eltel Analys
2026-06-30 Ework Group - Stabilising but volumes still await Ework Group Analys
2026-06-30 Ovzon - Renewed order with EU NATO customer Ovzon Analys
2026-06-26 Petrolia Noco - Q1 solid, May shut-in trims '26e ... Petrolia Noco Analys
2026-06-25 Embellence Group - Comps dictate Q2 performance Embellence .. Analys